NCT03525314

Brief Summary

The objective of this study is to examine how elongation of the Achilles tendon develops during the first year after rupture among patients with an Achilles tendon rupture, and how it affects physical function. The aim is to define a cutoff of acceptable elongation dividing the patients who obtain normal physical function (Limb Symmetry Index \> 90%) from those who do not. Patients treated both operatively and non-operatively will be included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 15, 2018

Completed
22 days until next milestone

Study Start

First participant enrolled

June 6, 2018

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2020

Completed
Last Updated

March 16, 2022

Status Verified

March 1, 2022

Enrollment Period

2.5 years

First QC Date

May 3, 2018

Last Update Submit

March 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Copenhagen Achilles Length Measure

    The examination of both the total and the free part of the achilles tendon of both the injured and un-injured leg is performed. The free part of the achilles tendon is defined as the distance between the proximal border of calcaneus and the musculotendinous junction of the soleus muscle. The total length of the achilles tendon is the distance between the proximal border of calcaneus and the musculotendinous junction of the medial gastrocnemius muscle. Measurement is perfomed as described by Barfod et al (1).

    Evaluation method after 12 months of started treatment

Secondary Outcomes (6)

  • Copenhagen Achilles Length Measure

    Evaluation method after 0-4 days, 3 weeks, 9 weeks, 4 months, 6 months of started treatment

  • Indirectly, clinical Achilles tendon length estimate

    Evaluation method after 9 weeks, 4, 6 and 12 months of started treatment.

  • Achilles tendon Total Rupture Score (ATRS)

    Evaluation method after 0-4 days, 3 weeks, 9 weeks, 4, 6 and 12 months of started treatment

  • Heel-rise Work test

    Evaluation method after 4, 6 and 12 months of started treatment.

  • Calf circumference

    Evaluation method after 9 weeks, 4, 6 and 12 months of started treatment

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients treated for acute Achilles tendon rupture at Amager-Hvidovre Hospital during the study period will be offered to participate in the study. The study cohort of study with uniqe clinical trials ID: Achilles HVH RCT is also included in this cohort.

You may qualify if:

  • Appointment in the Outpatients Department within 4 days of injury.
  • Total Achilles tendon rupture.
  • Initial treatment with split cast with the ankle in maximal plantar flexion must be started within 24 hours of injury.
  • The patient must be expected to be able to attend rehabilitation and postexaminations.
  • The patient must be able to speak and understand Danish.
  • The patient must be able to give informed consent.

You may not qualify if:

  • Rupture of the Achilles tendon either at the insertion on the calcaneus or at musculotendinous junction of the triceps surae.
  • Previous rupture of the Achilles tendon in any of the two legs.
  • Treated with Fluorquinolons or corticosteroids within the last 6 months.
  • In medical treatment of diabetes.
  • Suffers from rheumatic disease.
  • Other conditions prior to the injury resulting in reduced function of any of the two legs.
  • Contra-indication for surgery: severe arthrosclerosis with no palpable pulse in the foot, broken skin in the Achilles region of the injured leg.
  • Inability to lie in prone position on the operating table.
  • Terminal illness or severe medical illness: ASA (American Society of Anesthesiologists) score higher than or equal to 3.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physiotherapy and Orthopedical surgery, Copenhagen University Hospital, Amager-Hvidovre

Copenhagen, Hvidovre, DK-2650, Denmark

Location

Related Publications (1)

  • Barfod KW, Riecke AF, Boesen A, Hansen P, Maier JF, Dossing S, Troelsen A. Validation of a novel ultrasound measurement of achilles tendon length. Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3398-406. doi: 10.1007/s00167-014-3175-2. Epub 2014 Jul 20.

    PMID: 25038882BACKGROUND

Study Officials

  • Maria S Hansen, PT, MSc

    Copenhagen University Hospital, Amager-Hvidovre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 3, 2018

First Posted

May 15, 2018

Study Start

June 6, 2018

Primary Completion

December 10, 2020

Study Completion

December 10, 2020

Last Updated

March 16, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

There is no plan of sharing data with researchers not already included in this study.

Locations